Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- Nemluvio (nemolizumab)
- yellow fever vaccine
Interactions between your drugs
yellow fever vaccine nemolizumab
Applies to: yellow fever vaccine, Nemluvio (nemolizumab)
GENERALLY AVOID: The administration of live, attenuated viral or bacterial vaccines during nemolizumab therapy may be associated with a risk of disseminated infection due to enhanced replication of vaccine virus or bacteria in the presence of diminished immune competence. However, data evaluating the impact of nemolizumab treatment on the safety and effectiveness of these vaccines is not available.
MANAGEMENT: The manufacturer of nemolizumab recommends that the use of live, attenuated virus or bacterial vaccines be avoided during treatment with nemolizumab. Administration of all age-appropriate vaccines is recommended to be completed prior to initiation of nemolizumab, and in accordance with current immunization guidelines.
References (1)
- (2024) "Product Information. Nemluvio (nemolizumab)." Galderma Laboratories Inc
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Report options
- Switch to consumer interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Actemra
Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Adbry
Adbry is used to treat moderate-to-severe atopic dermatitis (eczema) in adults and children aged 12 ...
Arcalyst
Arcalyst (rilonacept) is used to treat Cryopyrin-Associated Periodic Syndromes, Deficiency of ...
Bimzelx
Bimzelx (bimekizumab) treats plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and ...
Cinqair
Cinqair (reslizumab) is a monoclonal antibody that affects the actions of the body's immune system ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Dupilumab
Dupilumab injection is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.